NICE rules out RA drug abatacept

The rheumatoid arthritis (RA) drug abatacept is too expensive to be prescribed on the NHS, according to NICE.

In a draft single technology appraisal of the drug, released last week, NICE said abatacept was as effective as the other cytokine inhibitor rituximab for RA, but cost twice as much.

Rituximab was recently approved for use with methotrexate in RA patients who failed to respond to other disease-modifying anti-rheumatic drugs (DMARDs).

A NICE spokesman said: 'While recognising the severity of RA, it was concluded that based on this evidence, abatacept could not be considered good use of NHS resources.'

Chief executive of the National Rheumatoid Arthritis Society Ailsa Bosworth said: 'To deny patients abatacept is to deny people with an aggressive and severe form of RA a chance of controlling the disease.'

Last week NICE issued final guidance on the use of tumour necrosis factor alpha blockers for RA. Adalimumab, etanercept and infliximab are recommended in patients with confirmed active RA who have already been trialled with at least two other DMARDs, including methotrexate.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Vaccination tracker

UK COVID-19 vaccination programme tracker

GPs across the UK have led the largest-ever NHS vaccination programme in response...

RCGP chair Professor Martin Marshall

Hand PCNs control of primary care infrastructure funding, says RCGP

CCG funding for primary care infrastructure should be handed to PCNs when the bodies...

Professor Martin Marshall and Talking General Practice logo

Podcast: RCGP chair Professor Martin Marshall

Talking General Practice speaks to RCGP chair Professor Martin Marshall.

Dr Chaand Nagpaul

In-house review not enough to stop 'unjust' GMC referrals, warns BMA

Doctors' leaders have repeated calls for a full independent review of the GMC referral...


How widespread is long COVID in the UK?

Millions of people in the UK are living with long COVID. GPonline looks at the data...

COVID-19 vaccination sign

GP contract for autumn COVID-19 booster campaign due shortly

GP practices in England will be invited shortly to sign up for the COVID-19 autumn...